Revenue for the mpox vaccine is down compared to last year however its travel va...
Maryland-based biotech Novavax experienced a clinical hold on its late-stage tri...
After the FDA approves Johnson & Johnson MedTech’s Varipulse technology for the ...
AbbVie saw its valuation drop by around $40 billion following disappointing resu...
The company has discontinued the Phase I/II trial of its only clinical candidate...
Adaptimmune’s Phase II IGNYTE-ESO trial investigating experimental T cell therap...
Metsera has brought in over $500m in funding in just seven months as it looks to...
The US Food and Drug Administration (FDA) has granted accelerated approval for P...
In Shanghai, more than 300 industry leaders, experts, and partners met to discus...
MSD has secured an exclusive worldwide license from LaNova Medicines for develop...
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human...
If confirmed as the HHS Secretary by the US Senate, RFK Jr will oversee federal ...
Following a re-evaluation, the EMA has recommended Eisai and Biogen’s Alzheimer’...
Discover the top sales and marketing intelligence solutions tailored for the pha...
Pfizer is currently assessing the potential divestiture of its hospital drugs un...
The FDA agreed for Novavax to continue trials of its vaccine combo after address...
